Captopril suppresses interstitial fibrin deposition in coxsackievirus B3 myocarditis

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 272, Issue 1 41-1, 1997, Pages

  Takada, Hitoshi ^a   Kishimoto, Chiharu ^a   Hiraoka, Yuji ^a   Kurokawa, Masahiko ^a   Shiraki, Kimiyasu ^a   Sasayama, Shigetake ^a,b  

^a UNIVERSITY OF TOYAMA   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

connective tissue matrix; fibrosis; myocyte hypertrophy

Indexed keywords

CAPTOPRIL; FIBRIN; MYOSIN; RETICULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONNECTIVE TISSUE; CONTROLLED STUDY; COXSACKIE VIRUS B3; FIBRIN DEPOSITION; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; HISTOPATHOLOGY; HYPERTROPHY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL; VIRUS MYOCARDITIS;

EID: 33750687576     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1997.272.1.h211     Document Type: Article

References (19)

1. Brown, L. F., J. F. Chester, R. A. Malt, and H. F. Dvorak. Fibrin deposition in autochthonous Syrian hamster pancreatic adenocarcinomas induced by the chemical carcinogen N-nitrosobis (2-oxopropyl) amine. J. Natl. Cancer. Inst. 78: 979-986, 1987.
2. Brown, L. F., A. M. Dvorak, and H. F. Dvorak. Leaky vessels, fibrin deposition, and fibrosis. A sequence of events common to solid tumors and to many other types of disease. Am. Rev. Respir. Dis. 140: 1104-1107, 1989.
3. Caforio, A. L. P., M. Grazzini, J. M. Mann, P. J. Keeling, G. F. Bottazzo, W. J. Mckenna, and S. Schiaffino. Identification of α- and β-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation 85: 1734-1742, 1992.
4. Cohen-Gould, L., T. F. Robinson, and S. M. Factor. Intrinsic connective tissue abnormalities in the heart muscle of cardiomyopathic Syrian hamsters. Am. J. Pathol. 127: 327-334, 1987.
5. Davison, G., C. S. Hall, J. G. Miller, M. Scott, and S. A. Wickline. Cellular mechanisms of captopril-induced matrix remodeling Syrian hamster cardiomyopathy. Circulation 90: 1334-1342, 1994.
6. Dvorak, H. F. Tumors. Wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 315: 1650-1659, 1986.
7. Hoh, J. F. Y., P. A. McGrath, and P. T. Hale. Electrophoretic analysis of multiple forms of cardiac myosin. Effects of hypophysectomy and thyroxine replacement. J. Mol. Cell. Cardiol. 10: 1053-1076, 1987.
8. Holubarsch, C. H., R. P. Goulette, R. A. Litten, L. A. M. Bjmulieri, and N. R. Alpert. The economy of isometric force development, myosin isoenzyme pattern and myofibrillar ATPase activity in normal and hypothyroid rat myocardium. Circ. Res. 56: 78-86, 1985.
9. Iwai, N., H. Shimoike, and M. Kinoshita. Cardiac renin-angiotensin system in the hypertrophied heart. Circulation 92: 2690-2696, 1995.
10. Izumo, S., B. Nadal-Ginard, and V. Mahdavi. All members of the MHC multigene family respond to thyroid hormone in highly tissue-specific manner. Science Wash. DC 231: 597-600, 1986.
11. Kaplan, E. L., and P. Meier. Nonparametric estimation from incomplete observation. J. Am. Stat. Assoc. 53: 457-462, 1958.
12. Khaw, B. A., J. A. Mattis, G. Melincoff, S. William, H. K. Gold, and E. Haber. Monoclonal antibody to cardiac myosin. Imaging of experimental myocardial infarction. Hybridoma. 3: 11-17, 1984.
13. Kishimoto, C., and W. H. Abelmann. In vivo significance of T cells in the development of coxsackievirus B3 myocarditis in mice. Immature but antigen-specific T cells aggravate cardiac injury. Circ. Res. 67: 589-598, 1990.
14. Kishimoto, C., C. Kawai, and W. H. Abelmann. Immunogenetic aspects of the pathogenesis of experimental viral myocarditis. In: Cardiomyopathy: Studies of Pathogenesis, edited by C. Kawai and W. H. Abelmann. Tokyo: Univ. of Tokyo Press, 1987, p. 3-7.
15. Kishimoto, C., T. Misaki, C. S. Crumpacker, and W. H. Abelmann. Serial immunological identification of lymphocyte subsets in murine coxsackievirus B3 myocarditis. Different kinetics and significance of lymphocyte subsets in heart and in peripheral blood. Circulation 77: 645-653, 1988.
16. Kojima, M., I. Shiojima, T. Yamazaki, I. Komuro, A. Yunzeng, W. Ying, T. Mizuno, K. Ueki, K. Tobe, T. Kadowaki, R. Nagai, and Y. Yazaki. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro. Circulation 89: 2204-2211, 1994.
17. Leslie, K. O., J. Schwarz, K. Sampson, and S. A. Huber. Progressive interstitial collagen deposition in coxsackievirus B3-induced myocarditis. Am. J. Pathol. 136: 683-693, 1990.
18. Lindpainter, K., W. Lu, N. Niedermajer, B. Schieffer, H. Just, D. Ganten, and H. Drexler. Selective activation of cardiac angiotensinogen gene expression in post-infarction ventricular remodeling of the rat. J. Mol. Cell. Cardiol. 25: 133-143, 1993.
19. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.